2019 European Pharma Market Research Conference, 29-30 Oct, Switzerland
October 29 - 30, 2019 - Hyperion Hotel Basel, Basel CHPharma Market Research Conference
ross@pharmamarketresearchconference.com
Phone:212-228-7974
The 6th Annual European Pharma Market Research Conference (October 29-30, 2019, Basel) is the best and largest industry assembly of market research executives in pharma, biotech, medical devices, and diagnostics. This prestigious event brings together the industry's top thought leaders and creates an environment of new ideas, relationships and perspectives. Reasons to attend: Strong Content Driven by Biotech & Pharma... Meet Pharma/Biotech Industry Influencers and Decision Makers... Diverse Sessions in Various Formats... Focus on Innovation... Latest Trends, Techniques and Best Practices... Advance Your Career... Fun Networking Events in a Relaxed Environment.Participants have come from these leading companies: Abbott, Actelion Pharmaceuticals Ltd, AplusA, Bayer, Biotest AG, Bluebird Bio, Bluefish Pharmaceuticals, Boehringer Ingelheim, Boehringer Ingelheim International GmbH, Branding Science, Branding Science UK Ltd, Bristol-Myers Squibb, Cello Health Insight, Edwards Lifesciences, Eisai Europe Ltd, Elma Research, eye square, Ferring, FirstWord Group, Fresenius Kabi Deutschland GmbH, Gilead Sciences Switzerland Sarl, GlaxoSmithKline, GSK, IBM Watson Health, Impact Health, Ipsos, Jazz Pharmaceuticals, Kantar Health, LEO Pharma, Lifescience Dynamics, Lonza, M Health, M3 Global Research, Medefield, Merck, Serono, Moor Consulting, MSD, The Neuromarketing Labs GmbH, Novaliq GmbH, Orthogen AG, Paedi Protect AG, PIERRE FABRE MEDICAMENT, PSYMA GROUP AG, Reframe Research, Research Aspects, Research Partnership, Roche, Sanofi, SERMO, SKIM, suAzio nv SurveyHealthcare, Teva Pharmaceuticals, Tillotts Pharma AG, UCB, Unither PharmaceuticalsThis event is unlike any other conference in Europe. It's immersive, interactive and focused on giving you and your colleagues the methodologies to deal with the new challenges and opportunities facing the industry.